This company has been acquired
LogicBio Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Key information
37.7%
Debt to equity ratio
US$5.93m
Debt
| Interest coverage ratio | n/a |
| Cash | US$30.78m |
| Equity | US$15.74m |
| Total liabilities | US$22.86m |
| Total assets | US$38.60m |
Recent financial health updates
Is LogicBio Therapeutics (NASDAQ:LOGC) Weighed On By Its Debt Load?
Jan 11
Does LogicBio Therapeutics (NASDAQ:LOGC) Have A Healthy Balance Sheet?
Aug 18Is LogicBio Therapeutics (NASDAQ:LOGC) Using Debt Sensibly?
Apr 12Recent updates
LogicBio jumps 648% on buyout deal with AstraZeneca unit Alexion
Oct 03Bullish: Analysts Just Made A Notable Upgrade To Their LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Forecasts
Aug 20LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 18LogicBio GAAP EPS of -$0.15, revenue of $3.2M
Aug 15Is LogicBio Therapeutics (NASDAQ:LOGC) Weighed On By Its Debt Load?
Jan 11Does LogicBio Therapeutics (NASDAQ:LOGC) Have A Healthy Balance Sheet?
Aug 18LogicBio EPS misses by $0.06, beats on revenue
May 10LogicBio announces agreements with CANbridge Pharma and Daiichi Sankyo
Apr 27Is LogicBio Therapeutics (NASDAQ:LOGC) Using Debt Sensibly?
Apr 12Is LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Popular Amongst Insiders?
Mar 08The LogicBio Therapeutics (NASDAQ:LOGC) Share Price Has Gained 12% And Shareholders Are Hoping For More
Jan 15LogicBio extends collaboration with Children's Medical Research Institute
Jan 07LogicBio Therapeutics names new CFO
Dec 22Looking In On LogicBio
Nov 17LogicBio reports Q3 results
Nov 09Financial Position Analysis
Short Term Liabilities: LOGC's short term assets ($32.8M) exceed its short term liabilities ($16.4M).
Long Term Liabilities: LOGC's short term assets ($32.8M) exceed its long term liabilities ($6.4M).
Debt to Equity History and Analysis
Debt Level: LOGC has more cash than its total debt.
Reducing Debt: Insufficient data to determine if LOGC's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LOGC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LOGC has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 15.8% each year.